Apyx Medical Corp. (APYX)
2.88
-0.17
(-5.57%)
USD |
NASDAQ |
Sep 10, 16:00
2.88
0.00 (0.00%)
After-Hours: 20:00
Apyx Medical Enterprise Value : 140.89M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 140.89M |
| September 08, 2026 | 140.89M |
| September 04, 2026 | 140.89M |
| September 03, 2026 | 141.32M |
| September 02, 2026 | 142.16M |
| September 01, 2026 | 140.89M |
| August 31, 2026 | 140.89M |
| August 28, 2026 | 142.16M |
| August 27, 2026 | 138.79M |
| August 26, 2026 | 140.89M |
| August 25, 2026 | 143.42M |
| August 24, 2026 | 142.16M |
| August 21, 2026 | 143.84M |
| August 20, 2026 | 140.05M |
| August 19, 2026 | 145.11M |
| August 18, 2026 | 143.42M |
| August 17, 2026 | 141.32M |
| August 14, 2026 | 140.05M |
| August 13, 2026 | 140.47M |
| August 12, 2026 | 138.37M |
| August 11, 2026 | 139.63M |
| August 10, 2026 | 158.16M |
| August 07, 2026 | 183.01M |
| August 06, 2026 | 187.64M |
| August 05, 2026 | 186.80M |
| Date | Value |
|---|---|
| August 04, 2026 | 192.70M |
| August 03, 2026 | 188.49M |
| July 31, 2026 | 185.12M |
| July 30, 2026 | 185.96M |
| July 29, 2026 | 174.17M |
| July 28, 2026 | 175.01M |
| July 27, 2026 | 176.27M |
| July 24, 2026 | 177.54M |
| July 23, 2026 | 173.75M |
| July 22, 2026 | 177.11M |
| July 21, 2026 | 185.96M |
| July 20, 2026 | 183.85M |
| July 17, 2026 | 192.70M |
| July 16, 2026 | 195.22M |
| July 15, 2026 | 198.59M |
| July 14, 2026 | 190.17M |
| July 13, 2026 | 191.86M |
| July 10, 2026 | 196.91M |
| July 09, 2026 | 200.28M |
| July 08, 2026 | 189.75M |
| July 07, 2026 | 189.33M |
| July 06, 2026 | 201.54M |
| July 02, 2026 | 193.54M |
| July 01, 2026 | 208.70M |
| June 30, 2026 | 201.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 209.75B |
| AngioDynamics, Inc. | 595.94M |
| Alphatec Holdings, Inc. | 1.881B |
| AtriCure, Inc. | 2.604B |
| Baxter International, Inc. | 19.29B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.072M |
| Revenue (Quarterly) | 13.88M |
| Total Expenses (Quarterly) | 17.13M |
| EPS Diluted (Quarterly) | -0.074 |
| Gross Profit Margin (Quarterly) | 39.59% |
| Profit Margin (Quarterly) | -22.13% |
| Earnings Yield | -7.00% |
| Normalized Earnings Yield | -7.000 |